F
N+ Score52
Vitamins & MineralsServing: 1 Tablet(s)Type: Non-Nutrient/Non-Botanical

Marcozyme by Marco Pharma Int'l is a multi-ingredient enzyme blend, categorized as a Non-Nutrient/Non-Botanical supplement, containing 7 total ingredients. Key components include Pancreatin (1225mg), Papain (300mg), Bromelain (300mg), and Rutin (300mg), alongside Trypsin (125mg) and Chymotrypsin (10mg). The product has an N+ Score of 52, earning an 'F' grade, indicating a below-average quality assessment. While label transparency is 100%, none of the listed ingredients are present at clinically studied dosages, and no specific underdosed ingredients were identified, suggesting potential for improved ingredient adequacy. This product may be considered by individuals interested in enzyme supplementation, though its overall quality score suggests areas for formulation enhancement.

About This Product

Marcozyme by Marco Pharma Int'l is a vitamins & minerals supplement containing 7 active ingredients. It has earned an N+ Score of 52/100 (Grade F).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness0/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity71/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (7 ingredients)

IngredientAmountDose Adequacy
Pancreatin1225.000 mgN/A
Bromelain300.000 mgN/A
Papain300.000 mgN/A
Rutin300.000 mgN/A
Trypsin125.000 mgN/A
Chymotrypsin10.000 mgN/A
Magnesium Aspartate10.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.